Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GMVDF
G Medical Innovations
$0.00
$0.00
▼
$0.03
$26K28.6611,627 shsN/A
SDCCQ
SmileDirectClub
$0.00
$0.00
▼
$0.01
$40K1.3566,098 shs1,000 shs
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$0.01
$0.00
$0.00
▼
$3.04
$29K0.03184,189 shs157 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.00
+200.0%		$0.00
$0.00
▼
$0.08
$13K7.99,556 shs1,005 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GMVDF
G Medical Innovations
0.00%0.00%0.00%0.00%0.00%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%0.00%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
0.00%0.00%+4,900.00%-96.35%-99.64%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
+200.00%-40.00%-40.00%+20.00%-60.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GMVDF
G Medical Innovations
$0.00
$0.00
▼
$0.03
$26K28.6611,627 shsN/A
SDCCQ
SmileDirectClub
$0.00
$0.00
▼
$0.01
$40K1.3566,098 shs1,000 shs
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$0.01
$0.00
$0.00
▼
$3.04
$29K0.03184,189 shs157 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.00
+200.0%		$0.00
$0.00
▼
$0.08
$13K7.99,556 shs1,005 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GMVDF
G Medical Innovations
0.00%0.00%0.00%0.00%0.00%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%0.00%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
0.00%0.00%+4,900.00%-96.35%-99.64%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
+200.00%-40.00%-40.00%+20.00%-60.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GMVDF
G Medical Innovations
0.00
N/AN/AN/A
SDCCQ
SmileDirectClub
0.00
N/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
1.00
SellN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GMVDF
G Medical Innovations
$4.42M0.00N/AN/AN/ANaN
SDCCQ
SmileDirectClub
$470.74M0.00N/AN/AN/ANaN
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$30.98M0.00N/AN/A$1.19 per share0.00
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.00N/AN/A($6.91) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GMVDF
G Medical Innovations
-$24.63MN/AN/AN/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
-$86.40M-$0.13N/AN/AN/AN/AN/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
-$10.09M-$1.41N/AN/AN/A-35.64%-476.73%-33.49%11/17/2026 (Estimated)
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08M-$3.89N/AN/AN/A-563.16%N/A-174.06%11/13/2026 (Estimated)
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GMVDF
G Medical Innovations
N/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GMVDF
G Medical Innovations
N/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
10.22
0.95
0.75
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24

Institutional Ownership

CompanyInstitutional Ownership
GMVDF
G Medical Innovations
5.96%
SDCCQ
SmileDirectClub
0.07%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
32.43%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%

Insider Ownership

CompanyInsider Ownership
GMVDF
G Medical Innovations
37.10%
SDCCQ
SmileDirectClub
64.70%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
40.92%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
GMVDF
G Medical Innovations
72259.92 million163.49 millionNot Optionable
SDCCQ
SmileDirectClub
2,700402.23 million142.12 millionNo Data
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
1205.89 million3.48 millionNot Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionNo Data

Recent News About These Companies

T2 Biosystems (NASDAQ:TTOO) Stock Price Crosses Above 50 Day Moving Average - Here's What Happened
September 18 at 2:42 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31030022
T2 Biosystems Inc.
May 19, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/ttoo/financials
T2 Biosystems to Wind Down Operations
February 4, 2026  |  360dx.com3
T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations
February 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/t2-biosystems-inc-announces-intent-155100394.html
T2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review
January 10, 2026  |  defenseworld.netD
In Hot Water: Jasmine Crockett Faces Probe Over Conflicting Financial Disclosures
November 11, 2025  |  dailysignal.comD
T2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis Report
October 21, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/t2-biosystems-inc-ttoo-2025-161000952.html
TTOO T2 Biosystems, Inc. - Seeking Alpha
June 25, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/TTOO
T2 Biosystems Inc. (TTOO) After Hours Quote
June 10, 2025  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/ttoo/after-hours
Despite Promising Technology, Did Operational Cost Structure Take Down T2 Biosystems?
March 5, 2025  |  360dx.com3
T2 Biosystems initiates major layoffs, seeks asset sale
February 22, 2025  |  uk.investing.comhttps://uk.investing.com/news/sec-filings/t2-biosystems-initiates-major-layoffs-seeks-asset-sale-93CH-3935537
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers
February 18, 2025  |  bizjournals.comhttps://www.bizjournals.com/boston/news/2025/02/18/t2-biosystems-layoffs-2025.html
T2 Biosystems to be delisted from Nasdaq
February 11, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/t2-biosystems-to-be-delisted-from-nasdaq/ar-AA1yPq3z
T2 Biosystems stock plunges to 52-week low of $0.22
January 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/t2-biosystems-stock-plunges-to-52-week-low-of-022/ar-AA1y85H6
T2 Biosystems Inc’s Stock Drama: Could This Be a Game-Changer for TTOO Investors?
January 24, 2025  |  bovnews.comB
T2 Biosystems stock plunges to 52-week low of $0.25
January 21, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/t2-biosystems-stock-plunges-to-52-week-low-of-025/ar-AA1xBmsK
T2 Biosystems amends loan terms, extends maturity date
January 18, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/t2-biosystems-amends-loan-terms-extends-maturity-date/ar-AA1xrlQ6
T2 Biosystems reports preliminary Q4 revenue $2.3M
January 7, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/t2-biosystems-reports-preliminary-q4-revenue-2-3m-1034201593
T2 Biosystems Reports Preliminary Financial Results For Q4 And Full Year 2024
January 7, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/t2-biosystems-reports-preliminary-financial-results-for-q4-and-full-year-2024-1034202039
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 7, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/t2-biosystems-announces-preliminary-fourth-140000525.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

G Medical Innovations NASDAQ:GMVDF

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

SmileDirectClub NASDAQ:SDCCQ

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee. On January 26, 2024, the voluntary petition of SmileDirectClub, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 29, 2023..

Strata Skin Sciences stock logo

Strata Skin Sciences NASDAQ:SSKN

$0.0050 0.00 (0.00%)
As of 09/18/2026 10:59 AM Eastern

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.0006 +0.00 (+200.00%)
As of 09/18/2026 02:39 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas